Giselle S. Magalhaes
Belo Horizonte, MG, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Oral or intranasal angiotensin-(1-7) improves anxiety and depression-like behaviors in mice subjected to allergic pulmonary inflammation.
Journal: Behavioural brain research
Published: March 31, 2025
Oral Angiotensin-(1-7) formulation after established elastase-induced emphysema suppresses inflammation and restores lung architecture.
Journal: Frontiers in pharmacology
Published: December 05, 2024
A single dose of angiotensin-(1-7) resolves eosinophilic inflammation and protects the lungs from a secondary inflammatory challenge.
Journal: Inflammation research : official journal of the European Histamine Research Society ... [et al.]
Published: December 16, 2023
Mechanisms of endothelial activation, hypercoagulation and thrombosis in COVID-19: a link with diabetes mellitus.
Journal: Cardiovascular diabetology
Published: October 18, 2023
Correction: Factors associated with arterial stiffness assessed by pulse pressure amplification in healthy children and adolescents: a cross-sectional study.
Journal: BMC pediatrics
Published: May 09, 2023
Factors associated with arterial stiffness assessed by pulse pressure amplification in healthy children and adolescents: a cross-sectional study.
Journal: BMC pediatrics
Published: August 25, 2022
Angiotensin-(1-7)/Mas receptor modulates anti-inflammatory effects of exercise training in a model of chronic allergic lung inflammation.
Journal: Life sciences
Published: April 06, 2021
Asthma: role of the angiotensin-(1-7)/Mas (MAS1) pathway in pathophysiology and therapy.
Journal: British journal of pharmacology
Published: March 31, 2021
Predictors and reference equations for augmentation index, an arterial stiffness marker, in healthy children and adolescents.
Journal: Clinics (Sao Paulo, Brazil)
Published: August 19, 2020
Activation of Ang-(1-7)/Mas Receptor Is a Possible Strategy to Treat Coronavirus (SARS-CoV-2) Infection.
Journal: Frontiers in physiology
Published: April 05, 2020
Treatment with inhaled formulation of angiotensin-(1-7) reverses inflammation and pulmonary remodeling in a model of chronic asthma.
Journal: Immunobiology
Published: February 05, 2020
Last Updated: 09/26/2026